APEIRON Biologics commences clinical COVID-19 trial with inhaled APN01

Written by Petra Hegmann on 12th October 2021. Posted in Client News.

[image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″]